Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK 4-component Strep A Vaccine in Healthy Adults
NCT07085702Phase 1Recruiting
- Sponsor
- GSK
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GSK4424989 in streptococcal infection (7 arms), sponsored by GSK. Primary endpoints: Number of participants with solicited administration site events, Number of participants with solicited systemic events and 5 more. Started Jul 2025; status: recruiting.
02
Drugs
GSK4424989
03
Conditions
streptococcal infection
Beyond the preview
Go deeper on NCT07085702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07085702.